Investor Relations

Financial Releases

Date Title and Summary Additional Formats
Toggle Summary Intersect ENT to Report Third Quarter 2017 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Oct. 16, 2017-- Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its third quarter on November 2, 2017 .
View HTML
Toggle Summary Intersect ENT Reports Second Quarter 2017 Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2017 .
View HTML
Toggle Summary Intersect ENT Reports Second Quarter 2017 Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Aug. 1, 2017-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2017 .
View HTML
Toggle Summary Intersect ENT to Report Second Quarter 2017 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its second quarter on August 1, 2017 .
View HTML
Toggle Summary Intersect ENT Reports First Quarter 2017 Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the first quarter ended March 31, 2017 .
View HTML
Toggle Summary Intersect ENT to Present at Bank of America Merrill Lynch 2017 Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq: XENT) a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced that management is scheduled to present an overview of the company's business at the Bank of America
View HTML
Toggle Summary Intersect ENT to Report First Quarter 2017 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its first quarter on May 2, 2017 .
View HTML
Toggle Summary Intersect ENT Reports Fourth Quarter and Full Year 2016 Results
Q4 2016 Revenue Increased 29% with Gross Margin of 84% Full Year 2016 Revenue Increased 28% with Gross Margin of 83% MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions,
View HTML
Toggle Summary Intersect ENT to Report Fourth Quarter and Year 2016 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its fourth quarter and year 2016 on February 28, 2017 .
View HTML
Toggle Summary Intersect ENT to Present at LEERINK Partners Global Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq:XENT) a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced that management is scheduled to present an overview of the company's business at the 6 th Annual LEERINK
View HTML